Young laboratory woman with testtubes

Recent News


aTen Therapeutics attends the BIA’s 15th Annual bioProcessUK Conference in Edinburgh, “Bioprocess Intensification – Driving down the cost of medicines”.

November 2018

aTen Therapeutics attends the Life Sciences Scotland conference in Glasgow, “Moving forward together: to 2025 and beyond”.

aTen Therapeutics

An innovative biotechnology company.

We are developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives.

Tensinomab product logo

Our novel antibody with huge therapeutic potential.

© aTen Therapeutics 2018. All rights reserved